Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNA

Liquid biopsy is a valuable precision oncology tool that is increasingly used as a non-invasive approach to identify biomarkers, detect resistance mutations, monitor disease burden, and identify early recurrence. The Tempus xF liquid biopsy assay is a 105-gene, hybrid-capture, next-generation sequen...

Descripción completa

Detalles Bibliográficos
Autores principales: Finkle, Justin D., Boulos, Hala, Driessen, Terri M., Lo, Christine, Blidner, Richard A., Hafez, Ashraf, Khan, Aly A., Lozac’hmeur, Ariane, McKinnon, Kelly E., Perera, Jason, Zhu, Wei, Dowlati, Afshin, White, Kevin P., Tell, Robert, Beaubier, Nike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253837/
https://www.ncbi.nlm.nih.gov/pubmed/34215841
http://dx.doi.org/10.1038/s41698-021-00202-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253837/
https://www.ncbi.nlm.nih.gov/pubmed/34215841
http://dx.doi.org/10.1038/s41698-021-00202-2

Ejemplares similares